These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16135497)

  • 1. Event-free survival of patients with high-risk neuroblastoma treated with an N6-like induction treatment.
    Valteau-Couanet D
    J Clin Oncol; 2005 Sep; 23(25):6262-3; author reply 6263. PubMed ID: 16135497
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloablative chemoradiotherapy versus continued chemotherapy for high risk neuroblastoma.
    Stram DO; Matthay KK; O'Leary M; Reynolds CP; Seeger RC
    Prog Clin Biol Res; 1994; 385():287-91. PubMed ID: 7972222
    [No Abstract]   [Full Text] [Related]  

  • 3. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience.
    Canete A; Gerrard M; Rubie H; Castel V; Di Cataldo A; Munzer C; Ladenstein R; Brichard B; Bermúdez JD; Couturier J; de Bernardi B; Pearson AJ; Michon J
    J Clin Oncol; 2009 Mar; 27(7):1014-9. PubMed ID: 19171715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease control intervals in high-risk neuroblastoma.
    Santana VM; Furman WL; McGregor LM; Billups CA
    Cancer; 2008 Jun; 112(12):2796-801. PubMed ID: 18429000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage IV neuroblastoma more than 1 year of age at diagnosis: major response to chemotherapy and survival durations correlated strongly with dose intensity.
    Cheung NK; Heller G; Kushner BH; Burch L; O'Reilly RJ
    Prog Clin Biol Res; 1991; 366():567-73. PubMed ID: 2068175
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of chemotherapy regimen using ifosphamide and carboplatin on recurrent or refractory neuroblastoma].
    Zhen ZJ; Sun XF; Xia Y; Wang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1550-2. PubMed ID: 17166384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004.
    Schmidt M; Simon T; Hero B; Eschner W; Dietlein M; Sudbrock F; Bongartz R; Berthold F; Schicha H
    Nuklearmedizin; 2006; 45(4):145-51; quiz N39-40. PubMed ID: 16964339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age at diagnosis and prognosis in children with neuroblastoma.
    Evans AE; D'Angio GJ
    J Clin Oncol; 2005 Sep; 23(27):6443-4. PubMed ID: 16116157
    [No Abstract]   [Full Text] [Related]  

  • 9. Can EPO reduce blood transfusion requirements during induction therapy for high-risk neuroblastoma?
    Cazzola M
    Nat Clin Pract Oncol; 2004 Nov; 1(1):22-3. PubMed ID: 16264794
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].
    Tang SQ; Huang DS; Wang JW; Feng C; Yang G
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):93-6. PubMed ID: 16613697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.
    George RE; Li S; Medeiros-Nancarrow C; Neuberg D; Marcus K; Shamberger RC; Pulsipher M; Grupp SA; Diller L
    J Clin Oncol; 2006 Jun; 24(18):2891-6. PubMed ID: 16782928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction for high-risk neuroblastoma.
    Kushner BH; Cheung NK
    Pediatr Blood Cancer; 2007 Sep; 49(3):221-3. PubMed ID: 17417798
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel intensive induction therapy for high-risk neuroblastoma utilizing sequential peripheral blood stem cell collection and infusion as hematopoietic support.
    Pradhan KR; Johnson CS; Vik TA; Sender LS; Kreissman SG
    Pediatr Blood Cancer; 2006 Jun; 46(7):793-802. PubMed ID: 16206215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criteria for optimizing prognostic risk groups in pediatric cancer: analysis of data from the Children's Oncology Group.
    Sposto R; London WB; Alonzo TA;
    J Clin Oncol; 2007 May; 25(15):2070-7. PubMed ID: 17513812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontraumatic chylothorax in a case of neuroblastoma.
    Seshachalam A; Nandennavar M; Laxmi LS; Sagar TG
    Indian J Cancer; 2010; 47(2):229-31. PubMed ID: 20448397
    [No Abstract]   [Full Text] [Related]  

  • 16. Profile and outcome of neuroblastoma with convertional chemotherapy in children older than one year: a 15-years experience.
    Bansal D; Marwaha RK; Trehan A; Rao KL; Gupta V
    Indian Pediatr; 2008 Feb; 45(2):135-9. PubMed ID: 18310793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A safer regimen for high-risk neuroblastoma.
    Felix CA
    Pediatr Blood Cancer; 2009 Jul; 53(1):3-6. PubMed ID: 19431215
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
    Matthay KK; Yanik G; Messina J; Quach A; Huberty J; Cheng SC; Veatch J; Goldsby R; Brophy P; Kersun LS; Hawkins RA; Maris JM
    J Clin Oncol; 2007 Mar; 25(9):1054-60. PubMed ID: 17369569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for neuroblastoma: does it hit the target?
    Matthay KK
    Lancet Oncol; 2008 Mar; 9(3):195-6. PubMed ID: 18308243
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
    Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.